Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1811-1820 of 2905 for cancer

Edit search filters
  1. Pilot Clinical Study To Evaluate Molecular Breast Imaging- Guidance For Sampling Of Breast Abnormalities In Patients With Known Or Suspected Breast Cancer

    Rochester, MN

  2. Nab-Paclitaxel And Bevacizumab In Treating Patients With Unresectable Stage IV Melanoma Or Gynecological Cancers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma

    Jacksonville, FL

  4. Safety And Efficacy Of ALLO-715 And ALLO-647 BCMA Allogenic CAR T Cells In In Adults With Relapsed Or Refractory Multiple Myeloma (UNIVERSAL)

    Rochester, MN

  5. A Study Of Rovalpituzumab Tesirine As Maintenance Therapy Following First-Line Platinum-Based Chemotherapy In Participants With Extensive Stage Small Cell Lung Cancer (MERU)

    Rochester, MN

  6. Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC).

    Scottsdale/Phoenix, AZ

  7. Safety And Efficacy Study Of MLN0128 In Combination With Exemestane Or Fulvestrant In Postmenopausal Women With ER/PR+ Metastatic Breast Cancer

    Rochester, MN

  8. A Study Of Siremadlin Alone And In Combination With Donor Lymphocyte Infusion In Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

    Jacksonville, FL

  9. Study Evaluating The Safety And Effectiveness Of JCARH125 In Subjects With Relapsed And/or Refractory Multiple Myeloma (EVOLVE)

    Rochester, MN

  10. A Study Evaluating The Safety And Effectiveness Of JCAR017 To Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Lymphoma (SLL)

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer